Roche announced the appointment of Omar Sherief Mohammad as Head India, Middle East & Africa (IMEA) within the Roche Diabetes Care (RDC) Global Commercial Organisation, based in Mumbai. Prior to this appointment, Mohammad has been General Manager RDC India since September 2019.
In this new capacity, Mohammad will play a key role in the shaping and executing of the overall commercial Go-To-Market Strategy, responsible for setting the strategic direction for IMEA, in alignment with the Global Commercial Organisation as well as the overall RDC strategy. In this newly created role, Mohammad will have direct oversight of IMEA and the RDC General Managers/Country Heads of these markets will directly report to him. Mohammad will also be General Manager in India.
Speaking about the new appointment, Mohammad said, “I strongly feel that there is a need for improving access to care in order to support the underprivileged section of the community by creating a holistic ecosystem for screening, awareness and education programs. I look forward to leading my teams across the IMEA region towards dedicating efforts to bend the curve of diabetes in terms of prevalence and adding value by bringing true relief for people with diabetes.”
“As GM India, Mohammad implemented a strategic patient-centric approach towards improving access to care. Under his leadership, RDC India pioneered the adoption of a Figital approach to enhance education and awareness about latest tech-enabled solutions to improve patient care. During his tenure, the company forged meaningful partnerships with like-minded public and private players to create a comprehensive eco-system of care to support underprivileged sections of the community. On the occasion of World Diabetes Day 2020, RDC India partnered with the Maharashtra state government to donate blood glucose monitoring devices to underprivileged people in rural Maharashtra. To further support the government in this time of covid-19 crisis, last year RDC India donated money to the PM relief fund and PPE kits to BMC hospitals in Mumbai,” informed the company in a statement.
As head of IMEA, Mohammad will steer the countries under his charge to amplify this patient-centric approach and collaborate with various stakeholders to address the burden of diabetes in the region.
Mohammad has two decades of experience in pharmaceutical sector, primarily in diabetes care, in India, global marketing in Denmark and emerging Asian markets. Prior to joining Roche, Mohammad was the VP and GM of Novo Nordisk, Vietnam and other Southeast Asia emerging markets.